Cas:327-20-8 6-TRIFLUOROMETHYL-1H-INDOLE-2-CARBOXYLIC ACID manufacturer & supplier

Chemical Name:6-TRIFLUOROMETHYL-1H-INDOLE-2-CARBOXYLIC ACID

CAS.NO:327-20-8

Synonyms:6-(Trifluoromethyl)-2-indole carboxylic acid;6-(Trifluoromethyl)-1H-indole-2-carboxylic acid;6-TRIFLUOROMETHYL-1H-INDOLE-2-CARBOXYLIC ACID;6-(Trifluoromethyl)indole-2-carboxylic acid;6-Trifluormethyl-indol-2-carbonsaeure;1H-Indole-2-carboxylic acid, 6-(trifluoromethyl)-;MFCD02664465

Molecular Formula:C₁₀H₆F₃NO₂

Molecular Weight:229.155

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:402.5±40.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.598

PSA:53.09000

Exact Mass:229.035065

LogP:2.88

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-(Trifluoromethyl)-2-indole carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD02664465 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Indole-2-carboxylic acid, 6-(trifluoromethyl)- Use and application,MFCD02664465 technical grade,usp/ep/jp grade.

Related News: But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 4-((4-(N-(2-(adamantan-1-ylamino)-2-oxoacetyl)sulfamoyl)phenyl)amino)-4-oxobutanoic acid manufacturers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 1H-Indazole, 5-nitro-3-(4-pyridinyl)-1-(tetrahydro-2H-pyran-2-yl)- suppliers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 2H-1,2,4,6-thiatriazine vendor & factory He joins us at a pivotal time as our Jinkō® platform goes from strength to strength as we expand our portfolio of partnerships. Grégoire’s strategic and operational expertise will be a vital part of our future success in accelerating and de-risking clinical trials. ,But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.